Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I highly doubt it. They want to get 10-Q out and out of the way before TLD, just to make sure nothing will be an obstacle to the good news and following take off. We might see the price drop a tiny bit on the 10-Q, but for those of us who have been following, there shouldn't be much in it we haven't already taken into account and discussed. I think Tuesday and Wednesday next week, if I was going to bet, but it is definitely not based on anything other than my gut feeling.
Doubt we will get TLD before 10-Q, which should be today or tomorrow, but I could be wrong.
It could be, but I heard TLD works well for that disease.
As per my Biotech CEO friend, The clinical trial registry is not at all that important during trials. It is a place to register your trial prior to commencement and the medical journal community has it as a requirement that you register before trial in order to get published. The registry is not run by FDA, but by NLM, National Library of Medicine.
Did you knock on the door and ask if you could get a tour of 'your' facilities as you are a part owner of the joint?
Couldn't agree more. Sad to see the rampant speculations going on here about things people have ZERO knowledge about.
I agree that we are soon to see a brief TLD telling us the endpoints are met. I think we need to get the 10-Q filed first, probably tomorrow, then next week could be the week. Like Gary, I believe we will definitely get it before Thanksgiving.
He could be a disgruntled software developer, who did not like my comments about coders, but enjoyed PM's retort about lawyers. LOL. I like it.
There's definitely investors protecting the upward move today and who don't want to see price drop below $1.25ish. It doesn't seem that hard to do as the shorts are scared of action like that and there's no regular selling going on.
I agree that taking calls and trying to say as little as possible is better than ignoring calls. There's a reason that companies have Investor Relations people. Normally he would be able to answer a lot of concerns investors might have, but on the doorstep of revealing results from a very long trial, there's not many things that are not related to the trial at this point.
In regard to some of the questions people have, there might be information in the 10-Q report which should be released by Friday, the latest. Even though the company usually does not release a PR when reporting earnings, the 10-Q will have some information we all might find noteworthy. I think that TLD 'COULD' be following shortly (Maybe next week) after the 10-Q, but I doubt it will come before, as that is not the standard practice.
Anders, I appreciate your input, but as a former corporate counsel, there's absolutely nothing in the transcribed remarks from LG that rises to any divulsion of inside information. Everything that was reported that he was saying was qualified with non certain wording and could never be construed as forward looking statements from a corporate officer. Just my two cents.
That being said, these individual communications with shareholders, while not illegal or prohibitive, are not ideal situations for a publicly traded company who are in a self imposed 'quiet period', leading up to the most important events in the company's history. It doesn't take much these days in a litigious society like the US to open a pandoras box of shareholder derivative suits, whether they are warranted or not. It could quickly become a nuisance and distraction, like AF's previous unmerited suit.
Thanks for the update.
EASY THERE, PM!!! No need to drag my profession into this. LOL. Drafting of agreements is where you can make up for some poor pre drafting negotiations. The longer the agreement, the more chance there is to insert items that will benefit your company long term. Depending on the lawyer on the other side and his experience with certain type agreements, you can actually influence the agreement in a positive way.
Good to see you back, PM. I could talk for a very long time about coders. Our in house programmers were on their own schedule, ALL THE TIME, so whenever we had software development that was not part of the main proprietary software we used, we would outsource the jobs to either Bulgarian firms or firms in India, which would save us a ton of money and get the software developed in no time. Our in-house IT developers did not like that, but in the long run I think it made them work faster as they thought we might eventually outsource the entire department.
I do the same. My cash account holdings are never touched, but I trade in my Roth account and accumulate extra shares without the tax burden from trading.
Oh, I forgot. That explain a lot of the frustration we are getting from the people across the pond. Stay safe and sane.
He might be down at the Pub, enjoying a cold one.
Thanks for the heads up. I was bored, so I was trading a little in my Roth account. Hate to get caught with my pants down, so will step aside and enjoy the few extra shares I picked up.
Doubt he will be able to answer any relevant questions we might have. Maybe see if he is allowed to tell you about Sawston completion, flaskworks process etc. Those are areas non-related to the trial.
Good to know.
I think (hope) you are right. I am confident in my own DD with this company. I have ignored a lot of people on this message board, whom I just don't feel contribute to the serious conversation. When investing in companies like this with a binary result, champagne or dogfood, you have to follow your own instincts. Mine says that so far there's nothing that makes me feel uncomfortable with my investment. That can obviously change as we move along on this journey. I am not planning on taking much/any profit unless I feel we reach a point where we might be short term overvalued. I will not say I wouldn't get back in if SP at that time reaches a level where I feel there's value. My general thought on valuation after positive TLD and regulatory approval, but before commercialization is in the $12-15 range, which would mean a fully diluted market cap of around $15-20B.
Not sure I ever mentioned coders, but yes, I have worked with coders. I think LP and LG are more like coders. They always did everything on their time. Figuring timelines for software development is likely the hardest thing I have ever been involved in my entire life.
At least not that spectrum. HAHAHA
The extension is 5 days for 10-Q's. 15 days is for annual reports and the like.
Quote from SEC:
"An extension of up to 15 calendar days is available for Form 10-K and up to 5 calendar days for Form 10-Q."
The rise in SP, have changed the valuation for the warrants and options, and have to be included in the Q-10. It is very standard operating procedure to get the 5 day extension if a lot of changes has happened in the quarter. This was expected and have been mentioned by posters yesterday.
PFE CEO stated that upon completion of trial, the placebo group will get the vaccine. That was a promise prior all the participants prior to signing up.
5 Calendar days max for quarterly results.
GGB, I don't know what price point you own your shares at. Mine is $0.55 after having started my position at $0.31 and averaged up. At $1.13 I do not feel LP has made me any poorer when looking at my portfolios value.
Do I want it to be a lot higher, as most people feel it should be? YES, We all feel that this stock could take off on positive TLD.
Do I feel that this should have already happened? YES, based on the timelines that company put forth back in August. I do feel that the collection of Data for DL was a lot harder than the company thought it would be, hence the announcement of DL on Oct. 5 and not a month earlier as they predicted.
Based on the Oct 5 DL, should we have had a PR with TLD? YES, but again, I think the process of putting together and analyzing the data from a very long trial took longer than they expected. I also have no insight into what factors the company could be contemplating, if any, and have to get solved before PR'ing TLD.
I agree that it would have been prudent to communicate with shareholders about delays in both TLD and in completion of Sawston Phase I, and that they could have done so without revealing any information about the trial. We know Sawston facility is moving along as posters have found new employees who started working there as well as advertisements looking for employees.
I understand the frustration of people on this board, but keep in mind that no one have been able to dig up anything negative about the science, the trial and any other issue regarding company, other than their timeline and our timeline seems not to match up. Don't let the frustration that things are taking longer get to you. Any delays prior to the last 3 months are in my mind not relevant as this is the first time that company have announced DL, which is a big event and should change everything that happens after that.
18,648M Shorts as of 10/30/20
All the posts that start with "Years ago........." are completely irrelevant at this time. NWBO is at a different stage right now. It might be the same actors involved, but post DL, everything has changed and the 'old' stories are not relevant anymore. The company is on the verge of entering the big leagues and not plodding around in the minors trying to find a swing (Getting the trial to the end).
I usually ignore AF's tweets, but I find this one very positive for NWBO. When he resorts to outright lies, it shows that him and his minions are getting desperate. Very good sign.
RLF-100 seemed to have great results in really sick patients with a 9 fold increase in 60 day survival rate at the time of results.
Isn't that what we are all hoping for?
Agree. The foundation/outline of the article could easily have been constructed before being unblinded as I am sure LL, Ashkan, et al. knew what they wanted to write and how they wanted to present the data. What needs to be done once unblinded is to add data, values, examples and conclusion. Though it won't be very fast to adapt the data to their outline, it shouldn't take very long time either. They have plenty of experience in writing these and will have the help of their assistants and staff to get this done.
You are right. I think the part of SOS that LG mentioned that was an item he had hit on the nail and that he couldn't comment on is the example he had in his article on the brief TLD PR. I think we should expect a very brief TLD PR in the near future. After that, it might be a while before they roll out the detailed version at either a conference or in a journal article. There are still information to PR after TLD, such as Sawston Phase I completion.
Patience, my fellow longs. We are sitting on a winner. Let LP and Co. do their thing and we will get to Bountyland. If you live in a warm weather place, go play golf and enjoy the fall. If not, put on some warm clothes and go for a walk.
This is not a placeholder. This is participation from LL, who might or might not have new things to bring up. She will speak regardless of how far NWBO has come with available public information.
We have a winner. The only questions remaining is timing. Timing of TLD is the first stepping stone. For most of us who are in it for the full trip to Bountyland, this one is not that important, as it really doesn't matter what the short term SP is. It is a human nature issue to get into the conversations about things influencing the short term SP, but in the scheme of things, kind of irrelevant. I am fine waiting 12-24 months before we reach Bountyland. There will be many milestones along the way. The only good thing about TLD sooner than later is that it means we are on our way.
Trumps feeble attempt to reduce drug prices will be futile, according to a friend of mine from law school who is currently working on the staff of a Republican senator. GOP was furious with him for the executive order, but calmed down when they realized it would have little effect. The Senate GOP's have prevented the Dems from pushing this through for years.